(Q46540109)

23 December 2017

title

The prognostic value of c-Kit, K-ras codon 12, and p53 codon 72 mutations in Egyptian patients with stage II colorectal cancer (English)

1 reference

23 December 2017

1 reference

7

1 reference

23 December 2017

author name string

Mostafa M El-Serafi

1

1 reference

23 December 2017

Abeer A Bahnassy

2

1 reference

23 December 2017

Nasr M Ali

3

1 reference

23 December 2017

Salem M Eid

4

1 reference

23 December 2017

Mahmoud M Kamel

5

1 reference

23 December 2017

Nayera A Abdel-Hamid

6

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

23 December 2017

number of pages

11

1 reference

inferred from page(s)

published in

Cancer

1 reference

23 December 2017

volume

116

1 reference

23 December 2017

issue

21

1 reference

23 December 2017

page(s)

4954-4964

1 reference

23 December 2017

Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

Correlation between p53 mutations and HPV in bilharzial bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

Guidelines 2000 for colon and rectal cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Prognostic significance of p53 mutations in colon cancer at the population level

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Mutations and allelic loss of p53 in primary tumor DNA from potentially cured patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.25417

1 reference

7 January 2021

Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Cyclooxygenase-2 in human pathological disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

c-kit proto-oncogene product is rarely detected in colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

TP53 mutations and codon 72 genotype--impact on survival among ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

The results of colorectal cancer treatment by p53 status: treatment-specific overview

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Prognostic importance of COX-2 expression in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25417

7 January 2021

Identifiers

DOI

10.1002/CNCR.25417

1 reference

23 December 2017

PubMed ID

20652953

1 reference

23 December 2017